VT News
Ralph Regula

Ralph Regula

Ask VT AI
View News Summary
  • Exelixis and Ensysce report strong biotech advances, with Exelixis' cancer drug Cabometyx driving revenue growth and Ensysce's opioid-use-disorder drug PF9001 showing promise.
  • Biden's health scrutinized again after prostate nodule found during routine exam, raising concerns about his fitness to serve.
  • States sue Trump administration over immigration-linked funding rules, arguing they violate the Constitution and could undermine public safety.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Exelixis and Ensysce report strong biotech advances, with Exelixis' cancer drug Cabometyx driving revenue growth and Ensysce's opioid-use-disorder drug PF9001 showing promise.
  • Biden's health scrutinized again after prostate nodule found during routine exam, raising concerns about his fitness to serve.
  • States sue Trump administration over immigration-linked funding rules, arguing they violate the Constitution and could undermine public safety.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Ralph Regula

Top Topics

Trending in U.S.

World

Sport